Stira Pharmaceuticals

H-1B salaries and sponsorship, from 21 certified filings (FY2025–FY2026)

Active H-1B filer · last filed FY2026 Q3
  • Other Professional, Scientific, and Technical Services
  • Main U.S. filing address: Fairfield, NJ
Median base salary$75,000−39% vs. all H-1B employers
Middle 50%$60k–$85k
Level II (mid-level) share48%all employers: 42%
Median prevailing wage$63,086the required minimum for these jobs and places

Is your Stira Pharmaceuticals offer competitive?

Enter the base salary in your offer. We compare it with Stira Pharmaceuticals's certified filings for the same job.

10th $60k25th $60kmedian $75k75th $85k90th $88k

Enter a salary to see where it falls.

Percentiles from Stira Pharmaceuticals's certified H-1B filings, base salary only. Jobs with at least 10 filings.

What Stira Pharmaceuticals hires for

Bar: share of Stira Pharmaceuticals's filings. Figure: median base salary.

Show all 1 jobs
JobMedianFilings
Quality Control Analyst$62,50010

Jobs with at least 10 filings at Stira Pharmaceuticals.

Pay by level

too fewLevel I
Entry-level · 33% of filings
$62.5kLevel II
Mid-level · 48% of filings
too fewLevel III
Senior · 5% of filings
too fewLevel IV
Expert · 14% of filings
Show the table

By experience level

Wage levelMedianFilings
Entry-level · Level I too few 7
Mid-level · Level II $62,500 10
Senior · Level III too few 1
Expert · Level IV too few 3

Median shown when a level has at least 10 filings.

Where Stira Pharmaceuticals files

Median base salary in each metro area. Rent: HUD Fair Market Rent, FY2027.

Show all 1 metro areas
Metro areaMedianFilings
New York, NY$67,50014

Salary details

Median salary$75,000
Middle 50%$60k–$85k
vs. all employers−39%comparison median $122,699
Filings21FY2025–FY2026 · latest two fiscal years

Salary range

Box: middle 50% of filings. Whiskers: 10th–90th percentile. 99% of filings are between $56,400 and $126,000.
PercentileSalary
10th$60,000
25th$60,000
50th (median)$75,000
75th$85,000
90th$88,000

Salary by year

Median salary

$50k $70k $90k FY2022: median $61,818 (15 filings) FY2024: median $62,500 (16 filings) FY2025: median $80,000 (15 filings) FY20 FY21 FY22 FY23 FY24 FY25 FY26

Filings per year

FY2020: 2 filings FY20 FY2021: 3 filings FY21 FY2022: 15 filings FY22 FY2023: 6 filings FY23 FY2024: 16 filings FY24 FY2025: 15 filings FY25 FY2026: 6 filings FY26 16
Shaded: FY2025–FY2026, the years behind the figures above. Median shown for years with at least 10 filings. FY2026 covers Q1–Q3 only.
Show as table
Fiscal yearMedianP25P75Filings
FY2020–––2
FY2021–––3
FY2022$61,818$60,000$67,50015
FY2023–––6
FY2024$62,500$58,750$87,50016
FY2025$80,000$65,000$85,00015
FY2026–––6

Pay vs. prevailing wage

Median offered salary$75,000
Median prevailing wage$63,086
Median difference+9.6%offered salary vs. prevailing wage, per filing
Filed at exactly the prevailing wage0%

Filing at exactly the prevailing wage does not mean low pay: at senior levels and in high-cost areas the prevailing wage itself is high.

About Stira Pharmaceuticals

Stira Pharmaceuticals's filings list its industry as Other Professional, Scientific, and Technical Services (Professional, Scientific, and Technical Services sector, NAICS 5419). Its main U.S. filing address is in Fairfield, NJ and its filings in the data run from FY2020 to FY2026 Q3. In the latest two fiscal years, the most filed jobs are Quality Control Analyst, Chemist and Operations Manager and the main metro areas are New York, NY. The most common wage level in those years is Level II (mid-level).

Questions

Does Stira Pharmaceuticals sponsor H-1B visas?

Yes. Stira Pharmaceuticals filed 21 certified H-1B Labor Condition Applications in FY2025–FY2026, the latest two fiscal years. The most recent filing in the data is from FY2026 Q3. A certified LCA is a step before the H-1B petition; it is not a visa approval.

How much does Stira Pharmaceuticals pay H-1B workers?

The median base salary on Stira Pharmaceuticals's H-1B filings is $75,000; half of filings fall between $60,000 and $85,000. Bonus and stock are not included.